ACHE and Alzheimer disease: The current therapeutic options against AD are composed by one N-methyl-d-aspartate (NMDA) receptor antagonist and three acetylcholinesterase (AChE) inhibitors, namely memantine (NMDA), donepezil, rivastigmine and galantamine (AChE)4.